ABOUT US

US Product Catalog

Molecular Kits

    • Simplexa™ C. difficile Universal Direct Kit

      MOL2975

      A real-time PCR assay for the in vitro qualitative direct detection of the toxin B gene (tcdB) of C. difficile. Extraction and amplification is performed in one protocol with no separate nucleic acid extraction step.

    • Simplexa™ C. difficile Direct Kit

      MOL2950

      The Simplexa™ C. difficile Direct assay is intended for use on the LIAISON® MDX (Integrated Cycler instrument) for the detection of Clostridium difficile toxin B gene (tcdB) present in liquid or unformed stool samples from individuals suspected of C. difficile infection (CDI).  This test aids in the diagnosis of illness resulting from CDI.

    • Simplexa™ Flu A/B & RSV Direct Kit

      MOL2650

      A real-time RT-PCR assay for the in vitro qualitative direct detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus (RSV) RNA. Extraction and amplification is performed in one protocol with no separate nucleic acid extraction step. Each kit includes three Direct Amplification discs. This product achieved moderate complexity status for use in CLIA moderate and high complexity healthcare facilities.

    • Simplexa™ Flu A/B & RSV Kit

      MOL2600

      A real-time RT-PCR assay intended for the in vitro qualitative detection and discrimination of influenza A, influenza B and respiratory syncytial virus (RSV).

    • Simplexa™ Group A Strep Direct Kit

      MOL2850

      A real-time PCR assay for the in vitro qualitative direct detection of Group A Strep bacterial DNA. Extraction and amplification is performed in one protocol with no separate nucleic acid extraction step.

    • Simplexa™ HSV 1 & 2 Direct Kit

      MOL2150

      A real-time PCR assay for the in vitro qualitative detection and differentiation of HSV-1 and HSV-2 DNA in cerebrospinal fluid (CSF) and genital swab samples from patients suspected of Herpes Simplex Virus (HSV) infections of the central nervous system (CNS) or genitalia.  Extraction and amplification is performed in one protocol with no separate nucleic acid extraction step. Each kit includes three Direct Amplification discs. This product achieved moderate complexity status for use in CLIA moderate and high complexity healthcare facilities.

    • Simplexa™ Influenza A H1N1 (2009) Kit

      MOL2500

      A real-time RT-PCR assay intended for the in vitro qualitative detection and differentiation of seasonal influenza A and 2009 H1N1 influenza viral RNA.